These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 19550368)

  • 1. Utility of diagnostic and prognostic markers in urothelial carcinoma of the bladder.
    Coleman JF; Hansel DE
    Adv Anat Pathol; 2009 Mar; 16(2):67-78. PubMed ID: 19550368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urothelial dysplasia and other flat lesions of the urinary bladder: clinicopathologic and molecular features.
    Hodges KB; Lopez-Beltran A; Davidson DD; Montironi R; Cheng L
    Hum Pathol; 2010 Feb; 41(2):155-62. PubMed ID: 19762067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p16ink4 immunoreactivity is a reliable marker for urothelial carcinoma in situ.
    Yin M; Bastacky S; Parwani AV; McHale T; Dhir R
    Hum Pathol; 2008 Apr; 39(4):527-35. PubMed ID: 18234280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical utility of immunohistochemistry in the diagnoses of urinary bladder neoplasia.
    Hodges KB; Lopez-Beltran A; Emerson RE; Montironi R; Cheng L
    Appl Immunohistochem Mol Morphol; 2010 Oct; 18(5):401-10. PubMed ID: 20505509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular and immunohistologic analyses cannot reliably solve diagnostic variation of flat intraepithelial lesions of the urinary bladder.
    Murata S; Iseki M; Kinjo M; Matsuzaki O; Moriuchi A; Ohtani H; Sakurai T; Satake T; Tsuzuki T
    Am J Clin Pathol; 2010 Dec; 134(6):862-72. PubMed ID: 21088148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic biomarkers in urothelial bladder cancer.
    Kim WJ; Kim YJ
    Expert Rev Mol Diagn; 2009 Apr; 9(3):259-69. PubMed ID: 19379084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dysregulation of mammalian target of rapamycin pathway in upper tract urothelial carcinoma.
    Munari E; Fujita K; Faraj S; Chaux A; Gonzalez-Roibon N; Hicks J; Meeker A; Nonomura N; Netto GJ
    Hum Pathol; 2013 Dec; 44(12):2668-76. PubMed ID: 24074531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular biomarkers for urothelial carcinoma of the bladder: challenges in clinical use.
    Bolenz C; Lotan Y
    Nat Clin Pract Urol; 2008 Dec; 5(12):676-85. PubMed ID: 19050710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An objective morphologic parameter to aid in the diagnosis of flat urothelial carcinoma in situ.
    Milord RA; Lecksell K; Epstein JI
    Hum Pathol; 2001 Sep; 32(9):997-1002. PubMed ID: 11567231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA damage in cytologically normal urothelial cells of patients with a history of urothelial cell carcinoma.
    Gontijo AM; Marcondes JP; Elias FN; de Oliveira ML; de Lima RO; Salvadori DM; de Camargo JL
    Environ Mol Mutagen; 2002; 40(3):190-9. PubMed ID: 12355553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular alterations associated with bladder cancer initiation and progression.
    Cordon-Cardo C
    Scand J Urol Nephrol Suppl; 2008 Sep; (218):154-65. PubMed ID: 18815930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Primary upper urinary tract tumors and subsequent location in the bladder].
    Azémar MD; Audouin M; Revaux A; Misraï V; Comperat E; Bitker MO; Chartier-Kastler E; Richard F; Cussenot O; Rouprêt M
    Prog Urol; 2009 Oct; 19(9):583-8. PubMed ID: 19800544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polypoid/papillary cystitis: a series of 41 cases misdiagnosed as papillary urothelial neoplasia.
    Lane Z; Epstein JI
    Am J Surg Pathol; 2008 May; 32(5):758-64. PubMed ID: 18379418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utility of a comprehensive immunohistochemical panel in the differential diagnosis of spindle cell lesions of the urinary bladder.
    Westfall DE; Folpe AL; Paner GP; Oliva E; Goldstein L; Alsabeh R; Gown AM; Amin MB
    Am J Surg Pathol; 2009 Jan; 33(1):99-105. PubMed ID: 18941404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estrogen and progesterone hormonal receptor expression in urothelial carcinoma of the bladder.
    Bolenz C; Lotan Y; Ashfaq R; Shariat SF
    Eur Urol; 2009 Dec; 56(6):1093-5. PubMed ID: 19596509
    [No Abstract]   [Full Text] [Related]  

  • 16. Soft tissue tumors of the urinary bladder, Part I: myofibroblastic proliferations, benign neoplasms, and tumors of uncertain malignant potential.
    Lott S; Lopez-Beltran A; Maclennan GT; Montironi R; Cheng L
    Hum Pathol; 2007 Jun; 38(6):807-23. PubMed ID: 17509394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How to combine the molecular profile with the clinicopathological profile of urothelial neoplastic lesions.
    van der Kwast TH
    Scand J Urol Nephrol Suppl; 2008 Sep; (218):175-84. PubMed ID: 18815932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular markers in bladder cancer.
    Shariat SF; Karam JA; Lerner SP
    Curr Opin Urol; 2008 Jan; 18(1):1-8. PubMed ID: 18090481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nest-like features in bladder, simulating the nested variant of urothelial carcinoma.
    Patriarca C; Colecchia M; Lopez-Beltran A; Sirugo G; Di Pasquale M; Bollito E
    Int J Surg Pathol; 2011 Feb; 19(1):11-9. PubMed ID: 20034978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular pathogenesis and diagnostics of bladder cancer.
    Mitra AP; Cote RJ
    Annu Rev Pathol; 2009; 4():251-85. PubMed ID: 18840072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.